Lpl Financial LLC Cti Biopharma Corp Transaction History

Lpl Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$4.45 - $6.17 $57,850 - $80,210	-13,000 Reduced 40.59%	19,024 $114,000
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $5,360 - $7,430	-1,000 Reduced 3.03%	32,024 $186,000
Q2 2022 Aug 12, 2022	SELL	$3.55 - $6.27 $50,410 - $89,034	-14,200 Reduced 30.07%	33,024 $197,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.86 $68,002 - $135,060	47,224 New	47,224 $117,000
Q2 2019 Aug 09, 2019	SELL	$0.8 - $1.03 $8,400 - $10,815	-10,500 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$0.9 - $1.37 $9,450 - $14,385	10,500 New	10,500 $10,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.